Skip to content

LGND

Ligand Pharmaceuticals Incorporated

Stock

$302.96+0.22 (+0.07%)Close Oct 2, 2026

Adjusted price

+68.20% total return, past year

Key statistics

Market cap
$6.0B
P/E (TTM)
32.5
52-week range
$177.73$322.61
Beta (5Y monthly)
1.18
Median dollar volume
$71.6M
Shares outstanding
19.9M
Revenue, last 12 months
$291M
Sector
Health Care
First close
Nov 18, 1992

Total

1M
+5.6%
YTD
+60.2%
1Y
+68.2%

Per year

3Y
+72.4%
5Y
+29.2%
10Y
+16.9%
20Y
+12.7%
Since 1992
+6.6%

Financials

Revenue

$291MLast 12 months

Gross profit

$141MLast 12 months

Operating income

$95MLast 12 months

Net income

$197MLast 12 months

EPS

$9.32Last 12 months

Free cash flow

$131MLast 12 months

Annual returns

1992 from Nov 18 · 2026 through Oct 2